Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FERMT2 | Q96AC1 | 4/20 | 0.61 |
| ▸ | HTR1A | P08908 | 5/20 | 0.55 |
| ▸ | ADRA1D | P25100 | 5/20 | 0.55 |
| ▸ | ADRA1A | P35348 | 5/20 | 0.55 |
| ▸ | ADRA1B | P35368 | 5/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CCNC | P24863 | 1/20 | 0.49 |
| ▸ | CDK8 | P49336 | 1/20 | 0.49 |
| ▸ | CCR1 | P32246 | 1/20 | 0.49 |
| ▸ | GAK | O14976 | 1/20 | 0.47 |
| ▸ | NCF1 | P14598 | 1/20 | 0.46 |
| ▸ | CDK1 | P06493 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iomethin SCHEMBL11883123 | 0.92 | FERMT2 (0.73) | FERMT2HTR1AADRA1DADRA1AADRA1B | |
| SCHEMBL12871598 | 0.86 | KDM4E (0.73) | FERMT2HTR1AADRA1DADRA1AADRA1B | |
| SCHEMBL17527056 | 0.85 | FERMT2 (0.67) | FERMT2KDM4ELMNAHTTHSD17B10 | |
| SCHEMBL4281985 | 0.83 | FERMT2 (0.85) | FERMT2KDM4ELMNAHTTHSD17B10 | |
| SCHEMBL12871600 | 0.82 | CDK1 (0.65) | FERMT2HTR1AADRA1DADRA1AADRA1B | |
| SCHEMBL12529450 | 0.81 | HTR1A (0.55) | FERMT2HTR1AADRA1DADRA1AADRA1B | |
| SCHEMBL12871542 | 0.81 | KDM4E (0.61) | FERMT2HTR1AADRA1DADRA1AADRA1B | |
| SCHEMBL12871372 | 0.81 | HTR1A (0.58) | FERMT2HTR1AADRA1DADRA1AADRA1B | |
| SCHEMBL8541628 | 0.80 | FERMT2 (0.57) | FERMT2HTR1AADRA1DADRA1AADRA1B | |
| SCHEMBL12871599 | 0.80 | KDM4E (0.60) | FERMT2HTR1AADRA1DADRA1AADRA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11739070-B2 | C5A receptor modulators | IDORSIA PHARMACEUTICALS LTD. (CH) | 2023-08-29 | — | — | US | disclosed |
| US-11530468-B2 | High-entropy alloys with high strength | THE TRUSTEES OF DARTMOUTH COLLEGE (US) | 2022-12-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11739070-B2 | C5A receptor modulators | C5AR1, C3AR1, C5AR2 | FERMT2 2103/4885HTR1A 219/4885ADRA1D 127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.